Author

Saskia Vermeer

Observed names: S. Vermeer, Saskia M. Vermeer

Observed institutions: Philips (Netherlands), bioMérieux (United Kingdom)

OpenAlex ID: A5000855494

Efficient amplification with NASBA® of hepatitis B virus, herpes simplex virus and methicillin resistant Staphylococcus aureus DNA

2008 · Birgit Deiman, Corinne Jay, et al. · Journal of Virological Methods · 23

HSV1 and HSV2 detection using a real-time DNA NASBA assay

2006 · D. van Strijp, C. Zintilini, et al. · Journal of Clinical Virology · 1

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer

2026 · N. de Gruil, A. F. de Groot, et al. · Breast Cancer Research

Abstract PO5-13-10: Determining tumor-driving cell signaling pathways in breast cancer: Support for targeted therapy selection

2024 · Paul van de Wiel, Yvonne Wesseling-Rozendaal, et al. · Cancer Research

Abstract 6221: Support for targeted therapy selection in triple negative breast cancer patients using aberrant signal transduction pathway activity profiles

2023 · Diederick M. Keizer, Yvonne J. Wesseling, et al. · Cancer Research

Abstract P2-08-18: Evaluation of the activity of key actionable oncogenic driving pathways in triple negative breast cancer using OncoSignal™; a novel molecular assay based on transcriptional profile analysis

2022 · Genevra Magliocco, Eveline den Biezen, et al. · Cancer Research

Abstract 740: A robust rapid mRNA based test to profile simultaneously ER, AR, PI3K and MAPK functional signaling pathway activity for precision oncology

2021 · Eveline den Biezen, Saskia Vermeer, et al. · Cancer Research

Development of a real-time NASBA for respiratory syncytial virus

2006 · P. van Aarle, B. Deiman, et al. · Journal of Clinical Virology

Works count: 8

Citation count: 24

H-index: 1

I10-index: 1